Request an Appointment

To request an appointment with our clinical team or for more information on our solutions and services, please complete the form provided or call our office at 786.780.1188. Rezilir is open for all in-person visits, however as the COVID-19 pandemic continues, we are offering all current and future patients the option of Telemedicine. Our dedicated Rezilir Health® staff will contact you as soon as possible. We look forward to welcoming you to our Rezilir family where Hope Is Happening.

  • This field is for validation purposes and should be left unchanged.

Applying ME/CFS (Chronic Fatigue Syndrome) Principles of Care to Long Covid

Feb 19th 2021 | By Dr. Craig Tanio MD, FACP, IFMCP

Long Covid and Chronic Fatigue Syndrome

There has been thirty years of clinical experience and research in ME/CFS that can be applied to Long Covid while the research is underway. Many of the principles and approach have been articulated in the 2020 version of the United States ME/CFS Clinician Coalition guidelines for Diagnosing and Treating ME/CFS. Rezilir is an active participant in research in fatiguing illness and is actively helping to create a multi-center registry on ME/CFS that includes the Neuroautoimmune Center led by Dr. Nancy Klimas.

We recognize that many patients with ME/CFS do not always receive the following in their care:

  • Access to a clinician who fully understands ME / CFS 
  • Recognition that their symptoms are real and can be addressed
  • Thorough differential diagnosis and approach that can address all root causes that are contributing to their symptoms
  • Sufficient and appropriate time between the clinician and the patient
  • Detailed coaching through practical health issues such as managing the energy envelope
  • Access through referrals to a specialist for co-morbid issues such as cranial cervical instability (CCI)

While the exact pathogenesis of the condition called ME/CFS is still unknown, it is clear that it is a complex chronic multifactorial syndrome. All patients need to have a thorough evaluation that incorporates a broad differential diagnosis including endocrine/metabolic, rheumatologic, neurologic, psychiatric, sleep, infectious, hematologic, gastrointestinal, cardiovascular, environmental exposures, and oncologic disorders. ME/CFS is often accompanied by a spectrum of co-morbid disorders such as fibromyalgia, irritable bowel syndrome, sleep disorder, autonomic dysfunction, autoimmune manifestations, effects of hazardous environmental exposure, latent chronic infections, posttraumatic experiences and/or limbic system activation.1 The therapeutic relationship building starts with a comprehensive medical history and physical exam. The detailed timeline of a patient’s life and illness helps discover root causes that can contribute to fatiguing illness.

Covid Fatigue text message on textured grunge copper and vintage gold background

There is a specific relationship between age, illness duration, and symptoms in ME/CFS. Research data illustrated a “crisis phase” earlier in the illness. The individuals who are in the early phase of their fatiguing illness need acute support and resources to deal with the devastating aspects.2 Timely evaluation is crucial for achieving desirable health outcomes. Early diagnosis and interventions can help the patient manage this chronic illness and possibly improve the quality of life.  Specific parts of an initial assessment will include:

  • Post-exertional malaise assessment – initiated with using PEM-focused questionnaires that may extend to an exercise physiology evaluation with cardiopulmonary exercise testing (CPET) to detect characteristic abnormalities and timely develop a personalized plan for patient’s physical activities within an “energy envelope.” This careful strategy may help stop physical deconditioning while ensuring the patient’s gain of physical strength.
  • Autonomic dysfunction assessment includes evaluating the patient’s subjective reports on the autonomic/orthostatic symptom scale, passive lean test following the NASA protocol. 
  • Cognitive evaluation which includes subjective and objective testing of cognitive function and imaging with NeuroQuant MRI if needed.
  • Laboratory/Biomarkers testing including testing for infections, immune dysfunction (e.g., cytokines, natural killer cells), genomics, neuroendocrine disbalance, autoimmunity, mitochondrial function, allergy, nutrition status, and environmental exposure markers.

Treatment needs to be tailored to the specific evaluation findings and potential root causes. While there are no FDA-approved pharmacologic treatment protocols for ME/CFS there are protocols that can address specific issues such as Postural Orthostatic Tachycardic Syndrome (POTS), Mast Cell Activation Syndrome (MCAS), cognitive dysfunction, and unrefreshing sleep. With Post Exertional Malaise (PEM), detailed coaching is provided to reduce the number of “crashes” and to help patients manage their energy envelope. There are several integrative and functional approaches to care that we offer onsite that in our clinical experience can improve functional status and help address root causes. These interventions can include but are not limited to:

  • Nutritional assessment and coaching to maintain a healthy diet 
  • Sleep interventions
  • Limbic system activation interventions
  • Osteopathic consultation and intervention to address Cranial Cervical Instability
  • Environmental assessment of indoor air pollution including mold and appropriate interventions to address mold and chemical exposures
  • Management of neuroinflammation and neurodegeneration including fatty acid treatments, hyperbarics, and compounded pharmaceuticals
  • Detoxification protocols if indicated by objective testing
  • Treatment of chronic infections (e.g., viral, tick borne infections) if indicated with herbs, antibiotics (if indicated), and immune support
  • Mitochondrial evaluation (e.g., transcriptomics) and appropriate support as indicated

1. Johnston S, Brenu EW, Staines D, Marshall-Gradisnik S. The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis. Clin Epidemiol. 2013;5:105-110. doi:10.2147/CLEP.S39876

2. U.S. ME/CFS Clinician Coalition. (2020). Resources for medical providers caring for people with myalgic encephalomyelitis/ chronic fatigue syndrome.

3. U.S. ME/CFS Clinician Coalition. US ME/CFS Clinician Coalition Letter: Post-COVID “LongHaulers” and ME/CFS. October 30, 2020

4. Naess H, Sundal E, Myhr K-M, Nyland HI. Postinfectious and chronic fatigue syndromes: clinical experience from a tertiary referral center in Norway. In Vivo. 2010;24(2):185-188.

5. Lyons D, Frampton M, Naqvi S, Donohoe D, Adams G, Glynn K. Fallout from the COVID-19 pandemic – should we prepare for a tsunami of post-viral depression? [published online ahead of print, 2020 May 15]. Ir J Psychol Med. 2020;1-6. doi:10.1017/ipm.2020.40

6. Moldofsky H, & Patcai JChronic widespread musculoskeletal pain, fatigue, depression, and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011 Mar 24; 11():37.

7. Chu L, Valencia IJ, Garvert DW, Montoya JG (2019). Onset, patterns and course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Frontiers in Pediatrics 7 (12). doi: 10.3389fped.2019.00012.

8. Xu J, Zhong S, Liu J, et al. Detection of severe acute respiratory syndrome coronavirus in the brain: potential role of the chemokine mig in pathogenesis. Clin Infect Dis. 2005;41(8):1089-1096. doi:10.1086/444461

Recent Blog Posts